 | Sight Sciences Inc (NASDAQ:SGHT) Director Staffan Encrantz Buys 86,454 Shares
americanbankingnews.com - December 1 at 11:07 PM |
| Insider Buying: Sight Sciences Inc (NASDAQ:SGHT) Director Purchases 214,606 Shares of Stock
americanbankingnews.com - December 1 at 11:07 PM |
| Sight Sciences (NASDAQ:SGHT) Trading Up 5%
americanbankingnews.com - November 30 at 2:54 PM |
| Sight Sciences (NASDAQ:SGHT) Shares Down 6.9%
americanbankingnews.com - November 29 at 1:30 PM |
| Sight Sciences (NASDAQ:SGHT) Shares Gap Up After Insider Buying Activity
americanbankingnews.com - November 24 at 10:13 AM |
| Sight Sciences Inc (NASDAQ:SGHT) CFO Jesse Selnick Buys 10,000 Shares
americanbankingnews.com - November 23 at 11:08 PM |
| Sight Sciences Inc (NASDAQ:SGHT) Short Interest Update
americanbankingnews.com - November 20 at 11:29 AM |
 | Sight Sciences to Participate in the Upcoming Piper Sandler Annual Healthcare Conference
finance.yahoo.com - November 18 at 7:00 PM |
| Sight Sciences (NASDAQ:SGHT) Reaches New 52-Week Low at $21.00
americanbankingnews.com - November 18 at 5:42 PM |
| Microinvasive Glaucoma Surgery with the OMNI® Surgical System is Associated with Diminished Diurnal IOP Fluctuations, a Significant, Independent Risk Factor for Glaucoma Progression
finance.yahoo.com - November 17 at 9:36 AM |
| Sight Sciences (NASDAQ:SGHT) Sets New 1-Year Low at $21.00
americanbankingnews.com - November 12 at 3:12 AM |
| Sight Sciences (NASDAQ:SGHT) Issues Earnings Results, Misses Estimates By $0.05 EPS
americanbankingnews.com - November 11 at 9:30 PM |
|
| Sight Sciences (NASDAQ:SGHT) Shares Gap Down Following Weak Earnings
americanbankingnews.com - November 11 at 10:14 AM |
| Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial of Canal Viscodilation in Combination with Cataract Surgery in Adults with Primary Open-Angle Glaucoma (POAG)
finance.yahoo.com - November 10 at 6:42 PM |
| Sight Sciences Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 10 at 6:42 PM |
| Wall Street Analysts Predict a 73% Upside in Sight Sciences, Inc. (SGHT): Here's What You Should Know
finance.yahoo.com - November 8 at 3:03 PM |
| Sight Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021
finance.yahoo.com - October 27 at 6:06 PM |
 | 5 Top Stock Gainers for Thursday: Tesla, HP, Netflix
thestreet.com - October 23 at 7:52 AM |
 | Thursday 10/21 Insider Buying Report: SGHT, TPL
nasdaq.com - October 23 at 7:52 AM |
| Wall Street Analysts See a 68% Upside in Sight Sciences, Inc. (SGHT): Can the Stock Really Move This High?
finance.yahoo.com - October 22 at 1:18 PM |
| Insiders Bet Big on These 2 ‘Strong Buy’ Stocks
finance.yahoo.com - October 22 at 8:18 AM |
| Director Of Sight Sciences Makes $12M Buy
finance.yahoo.com - October 21 at 3:15 PM |
| Sight Sciences Announces TearCare® Clinical Data Published in Cornea
finance.yahoo.com - October 20 at 9:01 AM |
| What Kind Of Shareholders Hold The Majority In Sight Sciences, Inc.'s (NASDAQ:SGHT) Shares?
finance.yahoo.com - October 15 at 2:12 PM |
| RSI Alert: Sight Sciences (SGHT) Now Oversold
nasdaq.com - September 19 at 12:16 AM |
| Sight Sciences, Inc. (SGHT)
realmoney.thestreet.com - September 17 at 11:36 PM |
| Sight Sciences Files Lawsuit Against Ivantis for Patent Infringement
finance.yahoo.com - September 16 at 8:17 PM |
| Sight Sciences to Participate in the Morgan Stanley Global Healthcare Conference
finance.yahoo.com - August 26 at 5:15 PM |
| Sight Sciences, Pioneering the Development of the Standalone MIGS Market, Announces Publication of Favorable Two-Year Outcomes of Standalone Use of the OMNI® Surgical System in Mild to Moderate Open-Angle Glaucoma
finance.yahoo.com - August 24 at 5:54 PM |
| Sight Sciences Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 12 at 4:55 PM |
 | Sight Sciences Inc.
barrons.com - August 6 at 7:30 PM |
| Sight Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
finance.yahoo.com - August 2 at 7:58 PM |
 | China’s central bank keeps sights set on monopolies
msn.com - July 31 at 2:40 PM |
| The NFL battle against Covid has no end in sight
msn.com - July 29 at 2:36 PM |
| Sight Sciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - July 27 at 4:45 PM |
| Sight Sciences Announces Multiple Presentations at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
finance.yahoo.com - July 27 at 4:45 PM |
